Garza-Hinojosa A, González-Cordero G

Language: Spanish
References: 30
Page: 257-262
PDF size: 178.71 Kb.

Text Extraction

No abstract.

REFERENCES

1. Palmer CM, Norris MC, Giudici MC, et al. Incidence of electrocardiographic changes during caesarean delivery under regional anesthesia. Anesth Analg. 1990;70:36-43.

2. McLintic AJ, Pringle SD, Lilley S, et al. Electrocardiographic changes during caesarean section under regional anesthesia. Anesth Analg. 1992;74:51-56.

3. Mathew JP, Fleisher LA, Rinehouse JA, et al. ST segment depression during labor and delivery. Anesthesiology, 1992;77:635-641.

4. Zakowski MI, Ramanathan S, Baratta JB, et al. Electrocardiographic changes during caesarean section: a cause for concern? Anesth Analg. 1993;76:162-167.

5. Spence A. Oxytocin during caesarean section. Anaesthesia. 2002;57:722-723.

6. Bolton TJ, Randall K, Yentis SM. Effect on the confidential enquires into maternal deaths on the use of syntocinon at caesarean section in the UK. Anaesthesia. 2003;58:277-279.

7. Moran C, Ni Bhuinneain M, Geary M, et al. Myocardial ischaemia in normal patients undergoing elective caesarean section: a peripartum assessment. Anaesthesia. 2001;56:1051-1058.

8. Chilvers JP, Cooper G, Wilson M. Myocardial ischaemia complicating an elective caesarean section. Anaesthesia. 2003;58:822-823.

9. Johnstone M. The cardiovascular effects of oxytocic drugs. Br J Anaesth. 1972;44:826-833.

10. Frank E. An accurate, clinically practical system for spatial vectorcardiography. Circulation. 1956;13:737-749.

11. Jensen SM, Johansson G, Osterman G, et al. On-line computerized vectorcardiography monitoring of myocardial ischemia during coronary angioplasty: comparison with 12-lead electrocardiography. Coron Artery Dis. 1994;5:507-514.

12. Sederholm M, Erhardt L, Sjögren A. Continuous vectorcardiography in acute myocardial infarction. Natural course of ST and QRS vectors. Int J Cardiol. 1983;4:53-63.

13. Trotter TN, Langton JA, Barker P, et al. Perioperative continuous monitoring of ST-segment changes in patients undergoing elective caesarean section. Br J Anaesth. 1992;69:352-355.

14. Häggmark S, Haney MF, Johansson G, et al. ST-segment deviations during pacing-induced heart rate increased in patients without coronary artery disease. Clin Physiol Funct Imaging. 2005;25:246-252.

15. Ragnarsson, U. The Nobel trail of Vincent du Vigneaud. J Pept Sci. 2007;13:431-433.

16. Rall TW. Oxytocin, prostaglandins, ergot alkaloids, and other drugs; tocolytic agents. In: Goodman GA, Rall TW, Nies AS, Taylor P, eds. Goodman and Gillman’s The Pharmacological Basis of Therapeutics, 8th ed. New York: Pergamon Press. 1990. pp. 933-953.

17. Katz RL. Antiarrhythmic and cardiovascular effects of synthetic oxytocin. Anesthesiology. 1964;25:653-661.

18. Córdoba G, Pizzi R, Millán A, Levy A, Potella P. Usefulness of intramuscular oxytocin on the cesarean section. Bol Hosp Univ Caracas. 1993;23:40-42.

19. Thomas JS. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section. Br J Anaesth. 2007;98:116-119.

20. Fortner CL, Manley ES Jr, Woodbury RA. Effects of synthetic oxytocin with and without preservatives upon coronary blood flow in the dog. J Pharmacol Exp Ther. 1969;165:258-266.

21. Evron S, Ariely S, Agasi M, et al. Severe peripheral arteriospasm following oxytocin administration. Am J Obstet Gynecol. 1986;155:657-658.

22. Oliver MF. Ischaemic heart disease in young women. Br Med J. 1974;4:253-259.

23. Kulka PJ, Scheu C, Tryba M, et al. Myocardial infarction during pregnancy. Anaesthesist. 2001;50:280-284.

24. Thomas TA, Cooper GM. Anaesthesia. In: Lewis G. editor. Why Mothers Die 1997-1999: The confidential enquiry into maternal deaths in the United Kingdom. London: RCOG Press. 2001. pp. 135-137.

25. Nordström L, Fogelstam K, Fridman G, et al. Routine oxytocin in the third stage of labour: a placebo controlled randomized trial. Br J Obstet Gynaecol. 1997;104:781-786.

26. Thomas JS, Koh SH, Cooper GM. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section. Br J Anaesth. 2007;98:116-119.

27. Cotter A, Ness A, Tolosa J. Prophylactic oxytocin for the third stage of labour (Review). Cochrane Database Syst Rev. 2001; CD001808.

28. Carvalho JC, Balki M, Kingdom J, et al. Oxytocin requirements at elective caesarean delivery: a dose-finding study. Obstet Gynecol. 2004;104:1005-1010.

29. Robinson M, Newman N, Creevy DC, et al. Congenital aortic stenosis in pregnancy. Ventricular fibrillation induced by oxytocin. JAMA. 1967;5:378-381.

30. Svanström MC1, Biber B, Hanes M, Johansson G, Näslund U, Bĺlfors EM. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section. Br J Anaesth. 2008;100:683-689.